Head-to-head · WeighScore
Medro vs Regenics
The verdict
Regenics takes it — 64/100 to 63.6/100, but only just.
Regenics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Regenics is a hybrid in-office and telemedicine health-optimization clinic based in Tarzana, CA, pairing compounded GLP-1 weight loss with TRT, blood panels, IV infusions, aesthetics, and more — patients… Medro is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Medro | Regenics |
|---|---|---|
| WeighScore | 63.6/100 | 64/100 |
| Grade | C | C |
| Scorecard rank | #256 | #250 |
| Semaglutide | $199/mo (compounded) | $199/mo (starting dose, compounded) |
| Tirzepatide | $299/mo (compounded) | $279/mo (starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #256 · C
Strengths
- Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
- LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
- No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
- Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).
Where it loses points
- Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
- Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
- Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
- Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.
Graded #250 · C
Strengths
- Hybrid model — in-office visits near Tarzana, CA plus national telemed
- Physical address published with a Google Maps link
- Phone support published — uncommon for DTC-only competitors
- Office hours clearly stated
- $139/mo first-month intro is competitive with the low end of the market
Where it loses points
- 503A pharmacy partner not named
- LegitScript certification not mentioned
- Full states-served list not disclosed
- 503A vs 503B designation not specified
- FDA compounded-medication disclaimer not visible on the homepage
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.